These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Increased bone alkaline phosphatase and isolated subcortical bone uptake of technetium-99m hydroxymethylene diphosphonate in the lower extremities in a patient with Graves' disease: a distinctly unusual variant of Graves' acropachy. Ogrin C Thyroid; 2008 Nov; 18(11):1227-9. PubMed ID: 19014329 [TBL] [Abstract][Full Text] [Related]
6. Visual vignette. Diagnosis: thyroid acropachy, the rare musculoskeletal manifestation of Graves' hyperthyroidism. Iqbal N; Diamond JM Endocr Pract; 2006; 12(2):234. PubMed ID: 16690475 [No Abstract] [Full Text] [Related]
7. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411 [TBL] [Abstract][Full Text] [Related]
8. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options. Bunevicius R; Prange AJ CNS Drugs; 2006; 20(11):897-909. PubMed ID: 17044727 [TBL] [Abstract][Full Text] [Related]
9. Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any). Bartalena L; Chiovato L; Vitti P J Endocrinol Invest; 2016 Oct; 39(10):1105-14. PubMed ID: 27319009 [TBL] [Abstract][Full Text] [Related]
10. Increased aggressiveness of thyroid cancer in patients with Graves' disease. Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978 [TBL] [Abstract][Full Text] [Related]